Publications
Medical Innovation
Detailed Technology Analysis - Home Telehealth
Publication Date: July 17, 2009
During 2008-2009, NEHI's Fast Adoption of Significant Technologies (FAST) initiative focused on telemedicine technologies that address chronic disease. Chronic disease is of particular concern because of the growing prevalence of illnesses such as diabetes and heart disease and the mounting costs these preventable conditions generate in the health care system. NEHI reviewed over 100 telemedicine technologies, identified the eleven considered most promising, and then examined in detail the two that were highest rated, Tele-stroke and Home Telehealth. NEHI completed Detailed Technology Analyses of each.
Detailed Technology Analysis - Tele-stroke
Publication Date: July 17, 2009
During 2008-2009, NEHI's Fast Adoption of Significant Technologies (FAST) initiative focused on telemedicine technologies that address chronic disease. Chronic disease is of particular concern because of the growing prevalence of illnesses such as diabetes and heart disease and the mounting costs these preventable conditions generate in the health care system. NEHI reviewed over 100 telemedicine technologies, identified the eleven considered most promising, and then examined in detail the two that were highest rated, Tele-stroke and Home Telehealth. NEHI completed Detailed Technology Analyses of each.
Balancing Act: Comparative Effectiveness Research and Innovation in U.S. Health Care
Publication Date: April 20, 2009
This white paper, representing the views of a broad range of health care stakeholders, provides a first-of-its-kind framework for designing and implementing a federal CER program that will sustain the unique dynamics of innovation in health care.
FAST Update: 2008-2009 Candidate Technologies
Publication Date: January 22, 2009
The FAST search for promising technologies initiated in 2008 was focused on identifying telemedicine technologies specifically used to treat chronic disease. The FAST team reviewed over 100 health care technologies in this area, narrowing them to the 11 most promising candidates detailed in this report.
Remote Physiological Monitoring: Research Update
Publication Date: January 21, 2009
Updated research on RPM technologies, emphasizing the cost effectiveness of RPM use compared to standard care and disease management practices, as well as remaining barriers to its adoption.
Comparative Effectiveness Research
Publication Date: July 21, 2008
A summary of NEHI's work in comparative effectiveness research.
Fast Adoption of Significant Technologies (FAST) One Page Summary
Publication Date: January 1, 2008
A joint partnership of NEHI, the Massachusetts Technology Collaborative and the Health Technology Center, FAST identifies and rates high-potential, underused medical technologies according to the patient population served, impact on outcomes, potential cost savings and barriers to adoption. By directing spending at high value areas, FAST is improving health care delivery and helping private payers make informed coverage decisions.
Tele-ICUs: Remote Management in Intensive Care Units
Publication Date: March 1, 2007
Tele-ICUs address the shortage in supply of intensivists in intensive care units (ICUs) by enabling a relatively small number of intensivists to oversee the care of a large number of ICU patients.
Challenges in Vaccine Policy: A Case Study of the HPV Vaccine
Publication Date: August 29, 2006
The HPV vaccine's immense promise in preventing cervical cancer -- and the barriers to its widespread adoption -- make it an ideal vehicle for implementing important improvements to the U.S. immunization system.
Continuous Glucose Monitoring: Innovation in the Management of Diabetes
Publication Date: March 1, 2005
CGM devices have potential to be highly valuable and cost-effective tools in managing diabetes.
Remote Physiological Monitoring: Innovation in the Management of Heart Failure
Publication Date: July 1, 2004
RPM provides substantial benefits to the health care system by reducing the number of hospital visits, length of stay and health care costs -- while improving quality of life -- for heart failure patients.
Targeting Cancer: Innovation in the Treatment of Chronic Myelogenous Leukemia
Publication Date: March 1, 2004
The adoption of Gleevec, a pioneering drug in the treatment of CML, highlights challenges and opportunities in bringing drugs treating rare diseases to market.
Phone:
Fax:
Email: